Page last updated: 2024-12-09

17-iodoheptadecanoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 17-Iodoheptadecanoic Acid (17-IHDA)

17-Iodoheptadecanoic acid (17-IHDA) is a long-chain fatty acid with an iodine atom attached to the 17th carbon atom. It's a synthetic compound, not naturally occurring in the body.

**Why is it important for research?**

17-IHDA is an important research tool because of its ability to **inhibit the enzyme carnitine palmitoyltransferase 1 (CPT1)**. This enzyme is crucial in the process of fatty acid oxidation, which is the breakdown of fats for energy.

**Here's how it works:**

* CPT1 is located in the outer mitochondrial membrane. It plays a vital role in transporting long-chain fatty acids into the mitochondria, where they can be broken down for energy production.
* 17-IHDA acts as a competitive inhibitor of CPT1. This means it binds to the same active site on the enzyme as the fatty acid substrate, effectively blocking the entry of fatty acids into the mitochondria.

**Research implications:**

* **Understanding fatty acid metabolism:** 17-IHDA is a valuable tool to study the role of CPT1 in various biological processes, such as energy production, lipid metabolism, and insulin sensitivity.
* **Developing new therapeutic strategies:** 17-IHDA has potential therapeutic applications in conditions related to metabolic disorders, such as:
* **Obesity:** 17-IHDA can reduce fat accumulation by inhibiting fatty acid oxidation, potentially leading to weight loss.
* **Diabetes:** 17-IHDA might improve insulin sensitivity by modulating the activity of CPT1 in skeletal muscles.
* **Cancer:** Some studies suggest that 17-IHDA could inhibit tumor growth by reducing fatty acid metabolism in cancer cells.

**Limitations:**

* 17-IHDA has been shown to have several side effects, including liver toxicity.
* Further research is needed to determine its long-term safety and efficacy for clinical use.

**In summary, 17-IHDA is a valuable research tool that allows scientists to study the role of CPT1 in fatty acid metabolism and explore its potential therapeutic applications in various metabolic disorders.** However, further research is needed to fully understand its potential benefits and risks.

17-iodoheptadecanoic acid: RN given refers to (123)I-labeled cpd; RN for unlabeled cpd not in Chemline 7/84 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2736656
SCHEMBL ID290324
MeSH IDM0088747

Synonyms (10)

Synonym
17-iodoheptadecanoic acid
60451-92-5
17-iodo-heptadecanecarboxylic acid
5(4h)-oxazolone, 4-[(4-fluorophenyl)methylene]-2-methyl-
SCHEMBL290324
mfcd00040783
17-iodo-heptadecanecarboxylic acid (iha)
FT-0738688
DTXSID30975858
CS-0454058

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The complex pharmacokinetic behavior of stable lipophilic catabolites prevents a quantitative background correction."( 15-(p[75Br]bromophenyl)pentadecanoic acid: pharmacokinetics and potential as heart agent.
Coenen, HH; Harmand, MF; Kloster, G; Stöcklin, G, 1981
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (55)

TimeframeStudies, This Drug (%)All Drugs %
pre-199043 (78.18)18.7374
1990's12 (21.82)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.23 (24.57)
Research Supply Index4.08 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.75%)5.53%
Reviews2 (3.51%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other54 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]